Emcure Pharmaceuticals debuts strongly in stock markets, hits ₹1,325 per share

Emcure Pharmaceuticals achieves a 31.45% IPO gain; Prashanth Tapse advises investors to hold for long-term growth

Subscribe To Our Free Newsletter